Molecular Stethoscope

company

About

Molecular Stethoscope, Inc., a San Diego, CA-based biotechnology company developing novel blood-based early detection.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$8.19M
Industries
Biotechnology,Health Care,Life Science,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy versus disease state.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$8.19M
Molecular Stethoscope has raised a total of $8.19M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2022 Grant 1 ADDF's Diagnostics Accelerator Detail
Jan 5, 2017 Seed $8.19M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Molecular Stethoscope is funded by 2 investors. ADDF's Diagnostics Accelerator and Pfizer are the most recent investors.
Investor Name Lead Investor Funding Round
ADDF's Diagnostics Accelerator Yes Grant
Pfizer Seed